Zivo Bioscience Inc. Warrants (ZIVOW) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Zivo Bioscience Inc. Warrants (ZIVOW) has a cash flow conversion efficiency ratio of -0.814x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-266.56K) by net assets ($327.67K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ZIVOW cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Zivo Bioscience Inc. Warrants - Cash Flow Conversion Efficiency Trend (2003–2024)
This chart illustrates how Zivo Bioscience Inc. Warrants's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Zivo Bioscience Inc. Warrants Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zivo Bioscience Inc. Warrants ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Latch Inc
NASDAQ:LTCHW
|
-0.134x |
|
WM Technology Inc
NASDAQ:MAPSW
|
0.047x |
|
African Agriculture Holdings Inc.
NASDAQ:AAGR
|
0.078x |
|
immatics biotechnologies GmbH
NASDAQ:IMTXW
|
-0.064x |
|
BELLHAVEN COPPER
F:4BL
|
N/A |
Annual Cash Flow Conversion Efficiency for Zivo Bioscience Inc. Warrants (2003–2024)
The table below shows the annual cash flow conversion efficiency of Zivo Bioscience Inc. Warrants from 2003 to 2024. For the full company profile with market capitalisation and key ratios, see Zivo Bioscience Inc. Warrants (ZIVOW) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-514.90K | $-4.31 Million | 8.377x | +218.61% |
| 2023-12-31 | $-2.21 Million | $-5.80 Million | 2.629x | -99.61% |
| 2022-12-31 | $-10.62K | $-7.10 Million | 668.670x | +59486.24% |
| 2021-12-31 | $6.04 Million | $-6.80 Million | -1.126x | -592.01% |
| 2020-12-31 | $-11.31 Million | $-2.59 Million | 0.229x | -48.53% |
| 2019-12-31 | $-8.34 Million | $-3.71 Million | 0.445x | +97.87% |
| 2018-12-31 | $-22.28 Million | $-5.01 Million | 0.225x | -13.66% |
| 2017-12-31 | $-16.30 Million | $-4.24 Million | 0.260x | +39.36% |
| 2016-12-31 | $-13.62 Million | $-2.54 Million | 0.187x | -22.79% |
| 2015-12-31 | $-9.50 Million | $-2.30 Million | 0.242x | -43.70% |
| 2014-12-31 | $-6.37 Million | $-2.74 Million | 0.430x | +38.01% |
| 2013-12-31 | $-9.59 Million | $-2.99 Million | 0.311x | -30.56% |
| 2012-12-31 | $-3.96 Million | $-1.77 Million | 0.448x | -29.64% |
| 2011-12-31 | $-2.03 Million | $-1.29 Million | 0.637x | -57.89% |
| 2010-12-31 | $-951.68K | $-1.44 Million | 1.513x | +397.95% |
| 2009-12-31 | $-3.79 Million | $-1.15 Million | 0.304x | -83.13% |
| 2008-12-31 | $-519.60K | $-935.82K | 1.801x | -3.29% |
| 2007-12-31 | $-755.37K | $-1.41 Million | 1.862x | -25.79% |
| 2006-12-31 | $-832.54K | $-2.09 Million | 2.510x | -10.22% |
| 2005-12-31 | $-590.09K | $-1.65 Million | 2.795x | +140.67% |
| 2004-12-31 | $-1.10 Million | $-1.28 Million | 1.161x | +139.94% |
| 2003-12-31 | $-35.94K | $-17.39K | 0.484x | -- |
About Zivo Bioscience Inc. Warrants
ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically act… Read more